<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38455320</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2674-1199</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in epidemiology</Title><ISOAbbreviation>Front Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Treated post-acute sequelae after COVID-19 in a German matched cohort study using routine data from 230,256 adults.</ArticleTitle><Pagination><StartPage>1089076</StartPage><MedlinePgn>1089076</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1089076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fepid.2022.1089076</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post-acute sequelae after COVID-19 are still associated with knowledge gaps and uncertainties at the end of 2022, e.g., prevalence, pathogenesis, treatment, and long-term outcomes, and pose challenges for health providers in medical management. The aim of this study was to contribute to the understanding of the multi-faceted condition of long-/ post-COVID. It was designed to evaluate whether a prior SARS-CoV-2 infection during the first COVID-19 wave in Germany increases the rate of disease, as measured <i>via</i> a record of insurance data on diagnoses, symptoms, and treatment, in the subsequent 12 months compared with matched control groups without recorded SARS-CoV-2 infection.</AbstractText><AbstractText Label="METHOD" NlmCategory="UNASSIGNED">50 outcome variables at disease, symptom and treatment levels (14 main categories and 36 sub-categories; new diagnoses) were defined from health insurance data. Logistic regression was carried out for two groups of patients tested positive in a PCR test in March/April 2020 for SARS-CoV-2, compared to the respective risk-adjusted (age, administrative region, 1:5 propensity-score matching), contemporaneous control group without prior documented SARS-CoV-2 infection (CG): First, individuals with outpatient treatment of acute COVID-19, indicating a not severe course (COV-OUT), and second, individuals with inpatient treatment of acute COVID-19, indicating a severe course (COV-IN) were compared with their respective control group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mortality rate in COV-OUT (<i>n</i>&#x2009;=&#x2009;32,378) and COV-IN (<i>n</i>&#x2009;=&#x2009;5,998) groups is higher compared to their control groups with odds ratio (OR) 1.5 [95%CI (1.3, 1.6)] and 1.7 [95%CI (1.5, 1.8)] respectively. Both groups were more likely to have experienced at least one outcome compared to their CG [OR&#x2009;=&#x2009;1.4, 95%CI (1.4, 1.4)]; OR&#x2009;=&#x2009;2.5, 95%CI [2.4, 2.6]). 42/37 (COV-IN/COV-OUT) outcome variables showed increased ORs. COV-OUT: Loss of taste and smell [OR&#x2009;=&#x2009;5.8, 95%CI (5.1, 6.6)], interstitial respiratory diseases [OR&#x2009;=&#x2009;2.8, 95%CI (2.0, 4.1)] and breathing disorders [OR&#x2009;=&#x2009;3.2, 95%CI (2.2, 4.7)] showed the highest ORs. COV-IN: Interstitial respiratory diseases [OR&#x2009;=&#x2009;12.2, 95%CI (8.5, 17.5)], oxygen therapy [OR&#x2009;=&#x2009;8.1, 95%CI (6.4, 10.2)] and pulmonary embolism/anticoagulation [OR&#x2009;=&#x2009;5.9, 95%CI (4.4, 7.9)] were the most pronounced.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Following a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic in Germany, 8.4 [COV-OUT, 95%CI (7.7, 9.1)] respectively 25.5 [COV-IN, 95%CI (23.6, 27.4)] percentage points more subjects showed at least one new diagnosis/symptom/treatment compared to their matched CG (COV-OUT: 44.9%, CG: 36.5%; COV-IN: 72.0%, CG: 46.5%). Because the symptoms and diagnoses are so varied, interdisciplinary and interprofessional cooperation among those providing management is necessary.</AbstractText><CopyrightInformation>&#xa9; 2023 M&#xfc;ller, Stengel, Roesler, Schillinger, Dr&#xe4;ther, G&#xfc;nster, Tillmanns, Erhart, Szecsenyi and Merle.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Doreen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>AOK Research Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stengel</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Practice and Health Services Research, Heidelberg University Hospital, Marsilius Arkaden, Turm West, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roesler</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AOK-Bundesverband, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schillinger</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AOK-Bundesverband, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xe4;ther</LastName><ForeName>Hendrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>AOK Research Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nster</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AOK Research Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tillmanns</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>AOK Research Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erhart</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department for Health and Rehabilitation Sciences, Alice-Salomon-Hochschule Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Psychology Department, Apollon Hochschule der Gesundheitswirtschaft, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szecsenyi</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Practice and Health Services Research, Heidelberg University Hospital, Marsilius Arkaden, Turm West, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merle</LastName><ForeName>Uta</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Clinic for Gastroenterology, Infectious Diseases, Toxicology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Epidemiol</MedlineTA><NlmUniqueID>9918419158106676</NlmUniqueID><ISSNLinking>2674-1199</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">post covid</Keyword><Keyword MajorTopicYN="N">post-acute sequelae</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>8</Day><Hour>3</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38455320</ArticleId><ArticleId IdType="pmc">PMC10911009</ArticleId><ArticleId IdType="doi">10.3389/fepid.2022.1089076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schilling J, Buda S, Tolksdorf K. Zweite aktualisierung der &#x201e;retrospektiven phaseneinteilung der COVID-19-pandemie in deutschland&#x201c; [second update of the &#x201c;retrospective phase classification of the COVID-19 pandemic in Germany]. Epid Bull. (2022) 10:3&#x2013;5. https://edoc.rki.de/bitstream/handle/176904/9483/EB-10-2022-Phaseneinteilung.pdf</Citation></Reference><Reference><Citation>Word Health Organization. Tracking SARS-CoV-2 variants.
https://www.who.int/activities/tracking-SARS-CoV-2-variants/
(Accessed October 30, 2022).</Citation></Reference><Reference><Citation>Robert-Koch-Institut. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Daten/Fallzahlen_Gesamtuebersicht.html
(Accessed October 30, 2022).</Citation></Reference><Reference><Citation>Perego E, Callard F, Stras L, Melville-J&#xf3;hannesson B, Pope R, Alwan N. Why the patient-made term &#x201c;long COVID&#x201d; is needed [version 1; peer review: 1 approved with reservations, 1 not approved]. Wellcome Open Res. (2020) 5:224. 10.12688/wellcomeopenres.16307.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhosh L, Block B, Kim SY, Raju S, Shah RJ, Thakur N, et al. Rapid design and implementation of post-COVID-19 clinics. Chest. (2021) 160(2):671&#x2013;7. 10.1016/j.chest.2021.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.03.044</ArticleId><ArticleId IdType="pmc">PMC8010340</ArticleId><ArticleId IdType="pubmed">33811910</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale HA, et al. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res. (2021) 8(1):1&#x2013;12. 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. (2022) 3(5):e221809-e. 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Stengel S, Hoffmann M, Koetsenruijter J, Peters-Klimm F, Wensing M, Merle U, et al. Long COVID: care and support needs from the perspective of &#x201c;long-haul&#x201d; patients and primary care practitioners - a mixed-methods study from baden-wuerttemberg. Z Evid Fortbild Qual Gesundhwes. (2022) 172:61&#x2013;70. 10.1016/j.zefq.2022.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zefq.2022.02.005</ArticleId><ArticleId IdType="pmc">PMC9212842</ArticleId><ArticleId IdType="pubmed">35717309</ArticleId></ArticleIdList></Reference><Reference><Citation>AWMF S1-Leitlinie Post-COVID/Long-COVID (Stand 17.08.2022);[ AWMF S1 Guideline Long/ Post-COVID (Status17.8.2022)]
https://www.awmf.org/leitlinien/detail/ll/020-027.html
(Accessed October 30, 2022).</Citation></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19;
https://www.nice.org.uk/guidance/NG188
(Accessed October 30, 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation. A clinical case definition of post COVID-19 condition by a Delphi consensus. 6 October 2021.
https://apps.who.int/iris/handle/10665/345824
(Accessed October 30, 2022).</Citation></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28(5):657&#x2013;66. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco JVA, Metzendorf M-I, Garegnani LI, Oltra G, Trivisonno LF, Sgarbossa N, et al. 
Symptome und langfristige Folgen von Long COVID &#x2013; eine systematische Evidenzsynthese.[Symptoms and Long-Term Consequences of Long COVID &#x2013; A Systematic Synthesis of Evidence]
https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Long-COVID/Evidenzanalyse.html
2022 (Accessed October 30, 2022).</Citation></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich H-G, Brockmann SO, G&#xf6;pel S, Kindle G, et al. Prevalence, determinants, and impact on general health and working capacity of post-acute sequelae of COVID-19 six to 12 months after infection: a population-based retrospective cohort study from southern Germany. BMJ. (2022) 379:1&#x2013;10. 10.1136/bmj-2022-071050</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. Late complications of COVID-19; a systematic review of current evidence. Arch Acad Emerg Med. (2021) 9(1):e14. 10.22037/aaem.v9i1.1058</Citation><ArticleIdList><ArticleId IdType="doi">10.22037/aaem.v9i1.1058</ArticleId><ArticleId IdType="pmc">PMC7927752</ArticleId><ArticleId IdType="pubmed">33681819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. Br Med J. (2021) 372:n693. 10.1136/bmj.n693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, et al. 6-month Mortality and readmissions of hospitalized COVID-19 patients: a nationwide cohort study of 8,679 patients in Germany. PLoS One. (2021) 16(8):e0255427. 10.1371/journal.pone.0255427</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255427</ArticleId><ArticleId IdType="pmc">PMC8341502</ArticleId><ArticleId IdType="pubmed">34351975</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID-mechanisms, risk factors, and management. Br Med J. (2021) 374:n1648. 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. (2021) 325(19):2015&#x2013;6. 10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. (2021) 27(4):601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. (2021) 27(9):1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. (2021) 36:100899. 10.1016/j.eclinm.2021.100899</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100899</ArticleId><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Seessle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. (2021) 74(7):1191&#x2013;98. 10.1093/cid/ciab611</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month Neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8(5):416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K, Ren S, Heath K, Dasmari&#xf1;as MC, Jubilo KG, Guo Y, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. Br Med J. (2022) 376:e068414. 10.1136/bmj-2021-068414</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesinstitut f&#xfc;r Bau-, Stadt- und Raumforschung (BBSR): Siedlungsstrukturelle Kreistypen.[Federal Institute for Research on Building, Urban Affairs and Spatial Development: District types of settlement structure]
https://www.bbsr.bund.de/BBSR/DE/forschung/raumbeobachtung/Raumabgrenzungen/deutschland/kreise/siedlungsstrukturelle-kreistypen/kreistypen.html
(Accessed November 28, 2022).</Citation></Reference><Reference><Citation>R&#xf6;&#xdf;ler M, Jacob J, Risch L, Tesch F, Enders D, Wende D, et al. Hierarchisierung von Risikofaktoren f&#xfc;r schwere COVID-19-Erkrankungsverl&#xe4;ufe im Kontext der COVID-19-Schutzimpfungen. Hierarchy of risk factors for severe COVID-19 disease progression in the context of COVID-19 vaccinations. Epidemiol. Bull. (2021) (19):3&#x2013;12. 10.25646/8405</Citation><ArticleIdList><ArticleId IdType="doi">10.25646/8405</ArticleId></ArticleIdList></Reference><Reference><Citation>The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement.
https://www.equator-network.org/reporting-guidelines/record/
(Accessed October 30, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595218</ArticleId><ArticleId IdType="pubmed">26440803</ArticleId></ArticleIdList></Reference><Reference><Citation>Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. (1996) 49(12):1373&#x2013;9. 10.1016/S0895-4356(96)00236-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(96)00236-3</ArticleId><ArticleId IdType="pubmed">8970487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. 
Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; united States, march 2020&#x2013;November 2021. MMWR. (2022) 71 (21): 713&#x2013;17. https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7121e1-H.pdf</Citation></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. (2020) 136(4):489&#x2013;500. 10.1182/blood.2020006520</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Duarte-Salles T, Fernandez-Bertolin S, Reyes C, Kostka K, Delmestri A, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. (2022) 22(8):1142&#x2013;52. 10.1016/S1473-3099(22)00223-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. (2022) 36(7):681&#x2013;702. 10.1007/s40263-022-00931-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-022-00931-3</ArticleId><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. The Lancet Psychiatry. (2022) 9:815&#x2013;27. 10.1016/S2215-0366(22)00260-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. (2022) 13(1):1957. 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, et al. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. (2021) 11(1):e044640. 10.1136/bmjopen-2020-044640</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-044640</ArticleId><ArticleId IdType="pmc">PMC7802392</ArticleId><ArticleId IdType="pubmed">33431495</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. (2022) 22(1):43&#x2013;55. 10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bosworth M. Office for National Statistics. Self-reported long COVID after infection with the Omicron variant in the UK 6 May 2022.
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections#long-covid
(Accessed October 30, 2022).</Citation></Reference><Reference><Citation>Statista. Durchschnittliche Lebenserwartung von Frauen nach Alter und Pflegebed&#xfc;rftigkeit im Zeitraum von 2005 bis 2010.[Statista. Average life expectancy of women by age and need for care in the period from 2005 to 2010.]
https://de.statista.com/statistik/daten/studie/170784/umfrage/lebenserwartung-von-frauen-nach-alter-und-pflegebeduerftigkeit/
(Accessed December 04, 2022).</Citation></Reference><Reference><Citation>Whittaker HR, Gulea C, Koteci A, Kallis C, Morgan AD, Iwundu C, et al. GP Consultation rates for sequelae after acute COVID-19 in patients managed in the community or hospital in the UK: population based study. Br Med J. (2021) 375:1&#x2013;13. 10.1136/bmj-2021-065834</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-065834</ArticleId><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz M, Mangiapane S, Scherer M, Karagiannidis C, Czihal T. Post-acute sequelae of SARS-CoV-2 infection&#x2014;characterization of community-treated patients in a case&#x2014;control study based on nationwide claims data. Dtsch Arztebl Int. (2022) 119:177&#x2013;8. 10.3238/arztebl.m2022.0134</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0134</ArticleId><ArticleId IdType="pmc">PMC9215269</ArticleId><ArticleId IdType="pubmed">35583040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge HHP, Muscat NA. Contribution from -, mishra S, nielsen S, tille F, pfeifer D, COVID Europe L, sivan M. Call for action: health services in the European region must adopt integrated care models to manage post-COVID-19 condition. Lancet Reg Health Eur. (2022) 18:100435. 10.1016/j.lanepe.2022.100435</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100435</ArticleId><ArticleId IdType="pmc">PMC9217062</ArticleId><ArticleId IdType="pubmed">35756854</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>